In leukemia, GATA1 mutations are involved in the pathogenesis of acute megakaryoblastic leukemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome patients [41]. The gene discussed is GATA1; the disease is transient myeloproliferative syndrome.